Investing Profile

Carl Gordon

Managing Partner at OrbiMed Advisors

Your Intro Paths to Carl Gordon

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Carl Gordon on

Current Investing Position

OrbiMed Advisors Managing Partner

Investment Range

$1M - $75.0M

Sweet Spot

$4.0M

Investments On Record

Carl Gordon is on these Sector & Stage Rankings

Carl Gordon's Investments On Record (33)

Company	StageDateRound Size	Total Raised
BlossomHill Therapeutics	Series BDec 2025$84M Series BJan 2024$100M Series AMar 2021$71M	$260M
Electra Therapeutics	Series COct 2025$180M Series BFeb 2022$84M	$270M
Co-investors: Beth Seidenberg (Kleiner Perkins)
Star Therapeutics	Series DSep 2025$130M Series CSep 2023$90M Series UnknownFeb 2022$100M	$320M
Co-investors: Jason P. Hafler (Sanofi Ventures), Maha Katabi (Sofinnova Investments), Beth Seidenberg (Kleiner Perkins)
RayThera	Series AApr 2025$110M	$110M
Co-investors: Michael Rome (Foresite Capital)
Stratus Therapeutics	Series AMar 2025$50M Series BFeb 2023$62M Series ASep 2021$72M	$180M
Co-investors: Shaan C. Gandhi (Longwood Fund), Eric Aguiar (Aisling Capital)
Alterome Therapeutics	Series BApr 2024$130M Series ANov 2022$35M Series AJan 2022$64M	$230M
Co-investors: Thilo Schroeder (Nextech Invest), Arjun Goyal (Vida Ventures)
ENYO Pharma	Series CJan 2024$28M Series BJun 2018$47M	$120M
Co-investors: Iain Dukes (OrbiMed)
ADARx Pharmaceuticals	Series CAug 2023$200M Series BJan 2023$46M Series BSep 2021$75M	$320M
Co-investors: Simeon J. George (SR One), Lorence Kim (Third Rock Ventures)